Activating KIR genes are associated with ankylosing spondylitis in Asian populations

Human Immunology

Volumn 69, Issue 7, 2008, Pages 437-442

  Díaz Peña, Roberto ^a   Blanco Gelaz, Miguel Angel ^a   Suárez Álvarez, Beatriz ^a   Martínez Borra, Jesús ^a   López Vázquez, Antonio ^a   Alonso Arias, Rebeca ^a   Brüges Armas, Jacome ^b   Vidal Castiñeira, Jose Ramón ^a   López Larrea, Carlos ^a,c  

^a HOSPITAL UNIVERSITARIO CENTRAL DE ASTURIAS   (Spain)

^b UNIVERSITY OF PORTO   (Portugal)

^c Section of Nephrology   (Spain)

Author keywords

Ankylosing spondylitis; HLA B27; KIR genes; Populations; Susceptibility

Indexed keywords

HLA B27 ANTIGEN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR;

ANKYLOSING SPONDYLITIS; ARTICLE; ASIAN; CHINA; CONTROLLED STUDY; DISEASE PREDISPOSITION; GENE; GENE ACTIVATION; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HUMAN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR GENE; MAJOR CLINICAL STUDY; POPULATION; PRIORITY JOURNAL; THAILAND;

ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CHINA; GENETIC PREDISPOSITION TO DISEASE; HUMANS; POLYMORPHISM, GENETIC; RECEPTORS, KIR; RECEPTORS, KIR2DL5; RECEPTORS, KIR3DL1; RECEPTORS, KIR3DS1; SPONDYLITIS, ANKYLOSING; THAILAND;

EID: 51749095265     PISSN: 01988859     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.humimm.2008.04.012     Document Type: Article

References (22)

1. González-Roces S., Alvarez M.V., González S., Dieye A., Makni H., Woodfield D.G., et al. HLA-B27 polymorphism and worldwide susceptibility to ankylosing spondylitis. Tissue Antigens 49 (1997) 116
2. Sims A.M., Wordsworth B.P., and Brown M.A. Genetic susceptibility to ankylosing spondylitis. Curr Mol Med 4 (2004) 13
3. Young H.L., Young H.R., Seong J.C., Jong D.J., and Gwan G.S. Ankylosing spondylitis susceptibility loci defined by genome-search meta-analysis. J Hum Genet 50 (2005) 453
4. Zhang G., Luo J., Bruckel J., Weisman M.A., Schumacher H.R., Khan M.A., et al. Genetic studies in familial ankylosing spondylitis susceptibility. Arthritis Rheum 50 (2004) 2246
5. Laval S.H., Timms A., Edwards S., Bradbury L., Brophy S., Milicic A., et al. Whole genome screening in ankylosing spondylitis: evidence of non MHC genetic-susceptibility loci. Am J Hum Genet 68 (2001) 918
6. Vivier E., and Anfossi N. Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 4 (2004) 190
7. Hsu K.C., Chida S., Geraghty D.E., and Dupont B. The killer cell immunoglobulin-like receptor (KIR) genomic region: gene-order, haplotypes and allelic polymorphism. Immunol Rev 190 (2002) 40
8. Lanier L.L., Corliss B.C., Wu J., Leong C., and Phillips J.H. Immunoreceptor DAP12 bearing a tyrosine-based activation motif is involved in activating NK cells. Nature 391 (1998) 703
9. Parham P. MHC class I molecules and KIRs in human history, health and survival. Nat Rev Immunol 5 (2005) 201
10. Khakoo S.I., and Carrington M. KIR and disease: a model system or system of models?. Immunol Rev 214 (2006) 186
11. Kollnberger S., Chan A., Sun M.Y., Chen L.Y., Wright C., di Gleria K., et al. Interaction of HLA-B27 homodimers with KIR3DL1 and KIR3DL2, unlike HLA-B27 heterotrimers, is independent of the sequence of bound peptide. Eur J Immunol 37 (2007) 1313
12. Lopez-Larrea C., Blanco-Gelaz M.A., Torre-Alonso J.C., Armas J.B., Suarez-Alvarez B., Pruneda L., et al. Contribution of KIR3DL1/3DS1 to ankylosing spondylitis in human leukocyte antigen-B27 Caucasian populations. Arthritis Res Ther 8 (2006) R101
13. Gumperz J.E., Litwin V., Phillips J.H., Lanier L.L., and Parham P. The Bw4 public epitope of HLA-B molecules confers reactivity with natural killer cell clones that express NKB1, a putative HLA receptor. J Exp Med 181 (1995) 1133
14. Carr W.H., Rosen D.B., Arase H., Nixon D.F., Michaelsson J., and Lanier L.L. Cutting Edge: KIR3DS1, a gene implicated in resistance to progression to AIDS, encodes a DAP12-associated receptor expressed on NK cells that triggers NK cell activation. J Immunol 178 (2007) 647
15. García-Fernández S., González S., Miña Blanco A., Martínez-Borra J., Blanco-Gelaz M.A., López-Vázquez A., et al. New insights regarding HLA-B27 diversity in the Asian population. Tissue Antigens 58 (2001) 259
16. Van der Linden S., Valkenburg H.A., and Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis. A proposal for modification of the New York Criteria. Arthritis Rheum 27 (1984) 361
17. Norman P., Stephens H.A., Verity D.H., Chandanayingyong D., and Vaughan R.W.J. Distribution of natural killer cell immunoglobulin-like receptor sequences in three ethnic groups. Immunogenetics 52 (2001) 195
18. Jiang K., Zhu F.M., Lv Q.F., and Yan L.X. Distribution of killer cell immunoglobulin-like receptor genes in the Chinese Han population. Tissue Antigens 65 (2005) 556
19. Suzuki Y., Hamamoto Y., Ogasawara Y., Ishikawa K., Yoshikawa Y., Sasazuki T., et al. Genetic polymorphisms of killer cell immunoglobulin-like receptors are associated with susceptibility to psoriasis vulgaris. J Invest Dermatol 122 (2004) 1133
20. Santin I., Castellanos-Rubio A., Perez de Nanclares G., Vitoria J.C., Castaño L., and Bilbao J.R. Association of KIR2DL5B gene with celiac disease supports the susceptibility locus on 19q13.4. Genes Immun 8 (2007) 171
21. Chan A.T., Kollnberger S.D., Wedderburn L.R., and Bowness P. Expansion and enhanced survival of natural killer cells expressing the killer immunoglobulin-like receptor KIR3DL2 in spondylarthritis. Arthritis Rheum 52 (2005) 3586
22. Stewart-Jones G.B., di Gleria K., Kollnberger S., McMichael A.J., Jones E.Y., and Bowness P. Crystal structures and KIR3DL1 recognition of three immunodominant viral peptides complexed to HLA-B*2705. Eur J Immunol 35 (2005) 341